- A novel myeloid cell line, Marimo, derived from therapy-related acute myeloid leukemia during treatment of essential thrombocythemia: consistent chromosomal abnormalities and temporary C-MYC gene amplification. Yoshida, H., Kondo, M., Ichihashi, T., Hashimoto, N., Inazawa, J., Ohno, R., Naoe, T. Cancer Genet. Cytogenet. (1998)









